Advertisement
Screener

BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Material Contracts, 2024

BRAINSTORM CELL THERAPEUTICS INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2024-09-16: Form 8-K; Exhibit 10.10; Description Amendment No. 4 to Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan..
  • 2024-09-16: Form 8-K; Exhibit 10.5; Description Amendment No. 4 to Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan..
  • 2024-08-14: Form 10-Q; Exhibit 10.10; Description Restricted Stock Agreement dated as of April 7, 2024 under the 2014 Global Share Option Plan between Brainstorm Cell Therapeutics Inc. and Uri Yablonka.
  • 2024-08-14: Form 10-Q; Exhibit 10.9; Description Restricted Stock Agreement dated as of April 21, 2024 under the 2014 Global Share Option Plan between Brainstorm Cell Therapeutics Inc. and Alla Patlis.
FiledFormExhibitDescription
2024-09-168-K10.10Amendment No. 4 to Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan.
2024-09-168-K10.5Amendment No. 4 to Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan.
2024-08-1410-Q10.10Restricted Stock Agreement dated as of April 7, 2024 under the 2014 Global Share Option Plan between Brainstorm Cell Therapeutics Inc. and Uri Yablonka
2024-08-1410-Q10.9Restricted Stock Agreement dated as of April 21, 2024 under the 2014 Global Share Option Plan between Brainstorm Cell Therapeutics Inc. and Alla Patlis
2024-08-1410-Q10.8Restricted Stock Agreement dated as of May 2, 2024 under the 2014 Stock Incentive Plan between Brainstorm Cell Therapeutics Inc. and Stacy Lindborg
2024-08-1410-Q10.7Restricted Stock Agreement dated as of June 3, 2024 under the 2014 Global Share Option Plan between Brainstorm Cell Therapeutics Inc. and Chaim Lebovits
2024-08-1410-Q10.2Separation Agreement dated April 16, 2024 between Brainstorm Cell Therapeutics Inc. and Stacy Lindborg
2024-08-1410-Q10.1Employment Agreement dated June 19, 2024 between Brainstorm Cell Therapeutics Inc. and Hartoun Hartounian
2024-06-288-K10.3Warrant Amendment Agreement, dated June 27, 2024.
2024-06-288-K10.2Placement Agency Agreement, dated as of June 27, 2024 by and between the Company and the placement agent party thereto.
2024-06-288-K10.1Form of Securities Purchase Agreement
2024-04-0110-K10.73Amendment No. 4 to Employment Agreement, effective as of August 1, 2022 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis
2024-04-0110-K10.72Amendment No. 3 to Employment Agreement, effective as of May 1, 2020 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis
2024-04-0110-K10.71Amendment No. 2 to Employment Agreement, effective as of April 1, 2019 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis
2024-04-0110-K10.70Amendment No. 1 to Employment Agreement, effective as of March 1, 2015 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis
2024-04-0110-K10.69Employment Agreement, dated as of December 23, 2012 by and between Brainstorm Cell Therapeutics Ltd. and Alla Patlis

Similar stocks

Stock NameCountryMarket CapPE Ratio
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
Pluri Inc. (PLUR)$0.014B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Passage BIO, Inc. (PASG)United States$0.015B-0.43
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37